Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Hot on Facebook
Man Tries to Order Priciest Starbucks Drink Ever Total cost: $23.60 »

NEWS ABOUT: medicine

Stories 121 - 140 | << Prev   Next >>

Switch to grid view »

Eye-Care Recall Reverberates on Wall Street

Product problem seen influencing bids for Bausch & Lomb

(Newser) - In the wake of reports linking its Complete MoisturePlus contact lens solution to a rare eye infection that can lead to blindness, Advanced Medical Optics has recalled the product. Competitor Bausch & Lomb's stock price dropped on the news, since the recall may put AMO's plans to enter the bidding... More »

Scientists ID New Breast Cancer Genes

Biggest breakthrough in a decade may advance prevention, treatment

(Newser) - Four newly discovered genes can increase a woman's chance of developing breast cancer by as much as 60%, say scientists who hail the isolation of the genes as the biggest advance in the field since 1994. The breakthrough raises hopes for more advanced treatment and even prevention of breast cancer... More »

New Cancer Ideas Compete for $1 Million

A Harvard doctor and two hedge fund managers set up contest for cancer cure

(Newser) - Doctors and hedge fund managers are joining forces to battle cancer with a million-dollar prize for the most imaginative new approach. The Gotham Prize for Cancer Research will be awarded to the most innovative essay—posted to the website—on finding a cure for cancer. Leading medical researchers will judge... More »

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug... More »

Diabetes Drug Ups Heart Risk

New study documents dangers of Avandia, but company nixes recall

(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found. More »

Psych Drugs Drove Kid Crazy

Careless prescriptions turned shy chess nerd into into belligerent hulk

(Newser) - The careless prescription of anti-psychotic drugs, often by psychiatrists who draw pay checks from the companies who make them, has drawn attention in the New York Times recently. Now Ann Bauer, writing in Salon, draws an intimate portrait of the effects of such carelessness on one autistic teenager, who turned... More »

Britain OKs Human-Animal Hybrids for Research

(Newser) - The British government has reversed its stance on the creation of human-animal hybrid embryos and will propose allowing scientists to use them as sources of stem cells. Scientists developing treatments for incurable diseases would be allowed to grow the hybrid embryos for no longer than two weeks, and implanting them... More »

Big Pharma Loses Generic Drug Fight

Deal for developing nations first blow by Dems in Congress

(Newser) - Congress and the White House have agreed to give developing nations more access to affordable generic drugs by easing some patent enforcement rules. Tucked into a broader trade agreement passed last week, the provision is the first blow to American pharmaceutical companies since the Democrats won control of Congress, the ... More »

Spider Venom the New Viagra

(Newser) - Men with erectile dysfunction may get an assist, believe it or not, from the Brazillian wandering spider—also dubbed the banana spider for its propensity to hide in bunches of the fruit. Researchers at Johns Hopkins have isolated a compound in the spider's deadly saliva that causes erections, der Spiegel... More »

OxyContin Maker Pleads Guilty

Manufacturer, execs admit misleading public about risky painkiller

(Newser) - The company that makes OxyContin pleaded guilty today to misleading the public about the effects of the potent painkiller. Purdue Pharma and three executives will pay $634.5 million in civil and criminal fines. Federal prosecutors accused the firm of "misbranding" the drug, marketing it as a less addictive... More »

Use of Antipsychotics For Kids Soars

Payments to psychiatrists from the drugs' makers soar at the same time

(Newser) - The Times tackles the growing use of antipsychotic drugs in children, contentious because the drugs are risky and have no approved use for minors. But the trend is also questionable because it coincides with increasing payments to psychiatrists by the companies that market the drugs. In Minnesota, these payments rose... More »

Doctors Paid Millions To Use Anemia Drugs

Among the world's top-selling medicines, the FDA now says they may be unsafe

(Newser) - Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports. More »

Toxic Cough Syrup Causes Deaths in Panama

How a tailor in China passed glycol off as glycerin, and killed hundreds of children

(Newser) - American drugmakers are on the lookout this week for another in the growing list of potentially deadly Chinese exports. This time, it's diethylene glycol, a sweet-but-toxic chemical that masquerades as glycerin in common medications like cough syrup and that has already killed almost 400 people—many of them children—in... More »

Researchers Link Gene, Heart Disease

Common variation dramatically increases risk

(Newser) - A gene that can more than double the risk of heart disease, especially in relatively young people, is present in about half of those of European descent, researchers say. The discovery, reported this week, raises hopes of more accurate genetic testing for heart disease—the world's leading cause of death—... More »

Lefty Women Die Younger

Stunner Dutch study shows 70% higher risk of dying from cancer

(Newser) - Left-handed women have a dramatically higher risk of mortality from just about every disease, a new study reported in the Telegraph shows. Dutch researchers who followed more than 12,000 women for nearly 13 years found lefties had a 40% greater chance of dying from any cause, 70% higher from... More »

Pharmaceutical Farming Generates Hopes and Fears

Benefits weighed against risk of food-supply contamination

(Newser) - The battle over genetic modification has a new player: "pharming," or pharmaceutical farming, which uses genetically modified plants to mass-produce drug compounds relatively inexpensively. By altering common plants—for instance, tobacco, which can be engineered to produce an HIV drug—researchers say pharming could transform the treatment of... More »

Research Gives Alzheimer's Patients Hope

New study suggests disease-related memory loss may be reversible

(Newser) - Alzheimer's patients may be able to recover some memory by using a combo of drugs and mental stimulation, a new study in the journal Nature concludes. Mice with an Alzheimer's-like condition were more likely to remember an electric shock if they had taken a drug stimulating brain-cell growth or lived... More »

Ouch—Doc's Trial Highlights Pain Issues

Was he trafficking narcotics or treating chronic pain?

(Newser) - The drug-trafficking trial of a Virginia pain specialist demonstrates the slippery slope between treating chronic conditions and enabling addicts. Dr. William Hurwitz's jury heard the story of a patient with deblitating migraines who had been treated with anxiety medication that actually caused headaches—by another doctor who happened to be... More »

Drug Targets Hundreds of Disorders

Magic bullet hits mutations that prompt 1,800 genetic diseases

(Newser) - A magic bullet that could treat cystic fibrosis, muscular dystrophy, hemophilia and more than 1,800 other genetic disorders could be available by 2009. Lee Sweeney of UPenn, leader of the team developing the drug, tells the Times of London: “It doesn’t just target one mutation that causes... More »

Breast Cancer Decline Tied to Hormone Drop

Study links 'colossal' reduction in cancer to women skipping estrogen

(Newser) - Researchers are linking a dramatic drop in the number of breast cancer cases to the decline in estrogen consumption by menopausal women. Women dropped hormone replacement therapy en mass after a 2002 study tied it to breast cancer risk. Other scientists argued that the decline—about 16,000 fewer new... More »

Stories 121 - 140 | << Prev   Next >>
NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne